VersaVIT is a vitrectomy system for the retinal surgery market.
“The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics’ strategy to enter into higher growth areas of retinal surgery,” said David Hable, president and CEO, in the release. “We believe that VersaVIT is a ‘game changer’ given its functionality, portability and competitive pricing relative to traditional vitrectomy systems.”
Synergetics USA is headquartered in O’Fallon, Mo.
Related Articles on FDA Clearances:
FDA Approves First Glaucoma Stent for Cataract Surgery
Cardinal Health Receives New FDA Clearance for Durablue Sterilization Wrap
InTouch Health Receives FDA 510(k) Clearance for Remote Presence Devices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.